- AU$6.05m
- -AU$2.25m
- AU$3.02m
Australia's Tissue Repair rises to 3-month high on securing distributor for flagship product
Brief: Tissue Repair Appoints Dion Cohen As CFO
Brief: Australian Government Takeovers Panel Receives Application From Tissue Repair
Brief: Australian Government Takeovers Panel Receives Application From Tissue Repair
Brief: Tissue Repair Says Tony Charara Appointed As CEO
Australia's Tissue Repair climbs on TGA product approval
Brief: Tissue Repair Says TGA Approval Granted For Tissue Repair's TR Pro
Australia's Tissue Repair eyes best day in over 7 months on US patent
Brief: Tissue Repair Ltd Says Third Us Patent Granted For Tissue Repair Glucoprime
Australia's Tissue Repair eyes best day ever on FDA phase 3 approval
Brief: Tissue Repair Says FDA Clears Phase 3 Clinical Program For Drug Candidate TR-987
Brief: Tissue Repair Expects To Be Able To Access Funds Held At SVB On 14 March
Brief: Tissue Repair Says Company Held Cash Of $2.188 Million With Silicon Valley Bank
Brief: Tissue Repair Posts Loss For HY Attributable A$3.2 Mln
Brief: Tissue Repair Receives Response From FDA Which Clarifies Path To Phase 3 Trials
Australia's Tissue Repair climbs on second U.S. patent
Brief: Tissue Repair Says FY Loss Attributable A$6.8 Million
Australia Stock Exchange release from TISSUE REPAIR : PRE_NR Ends: 10:30:54
Australia Stock Exchange release from TISSUE REPAIR : Tissue Repair Announces USA Patent Approval